Evidence map›Paper›PMID 20233798›Full record

ArticleEndocrinology2010

The ontogeny of insulin signaling in the preterm baboon model.

Cynthia L Blanco, Hanyu Liang, Joaquin Joya-Galeana, Ralph A DeFronzo, Donald McCurnin, Nicolas Musi

Open access · greenAbstract read
In one paragraph

Article in Endocrinology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Liver disease after intensive care of premature baboons: histopathologic observations.Journal of pediatric gastroenterology and nutrition · 2013
    Article
  12. Article
  13. Smad7 inhibits autocrine expression of TGF-β2 in intestinal epithelial cells in baboon necrotizing enterocolitis.American journal of physiology. Gastrointestinal and liver physiology · 2013
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Cynthia L BlancoDepartment of Pediatrics, Diabetes Division, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA. blanco@uthscsa.edu
Hanyu Liang
Joaquin Joya-Galeana
Ralph A DeFronzo
Donald McCurnin
Nicolas Musi
Texas Diabetes Institute · USThe University of Texas Health Science Center at San Antonio · USThe University of Texas Southwestern Medical Center · US

Funding

WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATESP51RR013986 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI GAUDUIN, MARIE-CLAIRE ELISABETH · 1999 to 2011
$79.1M
COLLABORATIVE PROGRAM IN BPDU01HL052636 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI COALSON, JACQUELINE JONES · 1999 to 2007
$18.1M
SGLT2 Inhibitors, Ketogenesis, and KetoacidosisR01DK024092 · NIDDK · YALE UNIVERSITY · PI RALPH A DEFRONZO · 1986 to 2026
$12.7M
Role of TLR4 on insulin resistance in humansR01DK080157 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MUSI, NICOLAS · 2008 to 2017
$3.0M
Role of IKK/lkB/NFkB Signaling in Insulin Resistance in Aging MuscleK23AG030979 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MUSI, NICOLAS · 2007 to 2009
$648k
Regulation of Hepatic and Peripheral Glucose MetabolismR56DK024092 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI DEFRONZO, RALPH A · 2005 to 2005
$73k
COLLABORATIVE PROGRAM IN BPDU10HL052636 · NHLBI · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI COALSON, JACQUELINE JONES · 1994 to 1998
–
COLLABORATIVE PROGRAM IN BPDR10HL052636 · NHLBI · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI COALSON, JACQUELINE JONES · 1994 to 1994
–
NCRR NIH HHS P51 RR013986NCRR NIH HHS P51RR13986NHLBI NIH HHS HL52636NHLBI NIH HHS U01 HL052636NIA NIH HHS AG030979NIA NIH HHS K23 AG030979NIDDK NIH HHS DK080157NIDDK NIH HHS DK24092NIDDK NIH HHS R01 DK024092NIDDK NIH HHS R01 DK080157NIDDK NIH HHS R56 DK024092
6 · The paper itself

Abstract

Hyperglycemia, a prevalent condition in premature infants, is thought to be a consequence of incomplete suppression of endogenous glucose production and reduced insulin-stimulated glucose disposal in peripheral tissues. However, the molecular basis for these conditions remains unclear. To test the hypothesis that the insulin transduction pathway is underdeveloped with prematurity, fetal baboons were delivered, anesthetized, and euthanized at 125 d gestational age (GA), 140 d GA, or near term at 175 d GA. Vastus lateralis muscle and liver tissues were obtained, and protein content of insulin signaling molecules [insulin receptor (IR)-beta, IR substate-1, p85 subunit of phosphatidylinositol 3-kinase, Akt, and AS160] and glucose transporters (GLUT)-1 and GLUT4 was measured by Western blotting. Muscle from 125 d GA baboons had markedly reduced GLUT1 protein content (16% of 140 d GA and 9% of 175 d GA fetuses). GLUT4 and AS160 also were severely reduced in 125 d GA fetal muscle (43% of 175 d GA and 35% of 175 d GA, respectively). In contrast, the protein content of IR-beta, IR substate-1, and Akt was elevated by 1.7-, 5.2-, and 1.9-fold, respectively, in muscle from 125 d GA baboons when compared with 175 d GA fetuses. No differences were found in the content of insulin signaling proteins in liver. In conclusion, significant gestational differences exist in the protein content of several insulin signaling proteins in the muscle of fetal baboons. Reduced muscle content of key glucose transport-regulating proteins (GLUT1, GLUT4, AS160) could play a role in the pathogenesis of neonatal hyperglycemia and reduced insulin-stimulated glucose disposal.

Indexed as

Signal TransductionAnimalsAnimals, NewbornBlood GlucoseBlotting, WesternDisease Models, AnimalFemaleGestational AgeGlucose Transporter Type 1Glucose Transporter Type 4HumansHyperglycemiaInsulinInsulin Receptor Substrate ProteinsLiverMaleBlood GlucoseGlucose Transporter Type 1Glucose Transporter Type 4InsulinInsulin Receptor Substrate ProteinsProto-Oncogene Proteins c-aktReceptor, Insulin

Identifiers

PMID20233798
PMCPMC2869258
OpenAlexW2055871971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.